Prime-and-pull vaccine may offer lasting genital herpes protection
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Prime-and-pull vaccine may offer lasting genital herpes protection" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include UC Irvine News, Inside Precision Medicine, News-Medical and Yale School of Medicine. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 143d ago.
Quick answers
Why is "Prime-and-pull vaccine may offer lasting genital herpes protection" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- Immunology researcher secures nearly $4 million NIH grant to advance therapeutic vaccine to help end genital herpes UC Irvine News · 146d ago
- Improving HSV-2 Vaccine Efficacy with Combination Strategy Inside Precision Medicine · 146d ago
- Prime and pull vaccine approach prevents genital herpes infection News-Medical · 146d ago
- Mucosal Adjuvant Boosts Immunity Against Genital Herpes Yale School of Medicine · 146d ago
- Prime-and-pull vaccine may offer lasting genital herpes protection Medical Xpress · 146d ago
Topics
Related trends
GLP-1s often contain untested additive combinations, study finds
After a GLP-1: Which Exit Strategy Keeps the Weight Off?
Cancer 'sponge' tests could be offered to more people with bad indigestion
NHS England draft guidance backs wider use of sponge-on-a-string tests for people with persistent heartburn, aiming to catch oesophageal cancer earlier.
Person at San Luis Obispo preschool recovering from E. coli complication
Taking GLP-1s forever? 5 strategies to keep weight off if you stop
New research outlines five evidence-based strategies to maintain weight loss after discontinuing GLP-1 medications like semaglutide and tirzepatide.